dc.contributor.author
Spieker, Johanne
dc.contributor.author
Vetter, Valentin Max
dc.contributor.author
Drewelies, Johanna
dc.contributor.author
Spira, Dominik
dc.contributor.author
Steinhagen‐Thiessen, Elisabeth
dc.contributor.author
Regitz‐Zagrosek, Vera
dc.contributor.author
Buchmann, Nikolaus
dc.contributor.author
Demuth, Ilja
dc.date.accessioned
2026-01-20T14:53:27Z
dc.date.available
2026-01-20T14:53:27Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/51204
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50931
dc.description.abstract
Aims
Aim of the current study was to describe the prevalence, incidence, and severity of diabetes mellitus type 2 (T2D) in a cohort of older men and women aged 60 years and above over the course of on average 7 years, since longitudinal data on this topic are scarce for this age group in Germany.
Methods
Baseline data of 1671 participants of the Berlin Aging Study II (BASE-II; 68.8 ± 3.7 years) and follow-up data assessed 7.4 ± 1.5 years later were analysed. The BASE-II is an exploratory, observational study on cross-sectional and longitudinal data of an older population. T2D was diagnosed based on self-report, antidiabetic medication use and laboratory parameters. T2D severity was determined by the diabetes complications severity index (DCSI). Prognostic capacity of laboratory parameters was evaluated.
Results
The proportion of participants with T2D increased from 12.9% (37.3% women) at baseline to 17.1% (41.1% women) with 74 incident cases and 22.2% not being aware of the disease at follow-up. The incidence rate is 10.7 new T2D diagnoses per 1000 person-years. More than half of the 41 newly identified incident T2D cases were diagnosed solely by the 2 h-plasma glucose test (OGTT) and diagnosis based on OGTT as the only criterion among incident cases was found more frequently in women (p = 0.028). T2D severity expressed by the DCSI significantly increased from baseline to follow-up (mean DCSI 1.1 ± 1.2 vs. 2.0 ± 1.8; range 0–5 vs. 0–6). Cardiovascular complications had the highest impact (43.2% at baseline and 67.6% at follow-up).
Conclusions
A comprehensive picture of T2D with respect to prevalence, incidence, and severity in older people of the Berlin Aging Study II is provided.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Berlin Aging Study II
en
dc.subject
diabetes mellitus type 2
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Diabetes type 2 in the Berlin Aging Study II: Cross-sectional and longitudinal data on prevalence, incidence and severity over on average seven years of follow-up
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e15104
dcterms.bibliographicCitation.doi
10.1111/dme.15104
dcterms.bibliographicCitation.journaltitle
Diabetic Medicine
dcterms.bibliographicCitation.number
8
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.volume
40
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37012605
dcterms.isPartOf.issn
0742-3071
dcterms.isPartOf.eissn
1464-5491